Effect of add-on direct renin inhibitor aliskiren in patients with non-diabetes related chronic kidney disease

BACKGROUND: The renin-angiotensin-aldosterone system (RAAS) plays an important role in the progression of chronic kidney disease (CKD). Although dual RAAS inhibition results in worse renal outcomes than monotherapy in high risk type 2 diabetes patients, the effect of dual RAAS inhibition in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Szu-yuan, Chen, Yung-Tai, Yang, Wu-Chang, Tarng, Der-Cherng, Lin, Chih-Ching, Yang, Chih-Yu, Liu, Wen-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3509390/
https://www.ncbi.nlm.nih.gov/pubmed/22917002
http://dx.doi.org/10.1186/1471-2369-13-89

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3509390/
https://www.ncbi.nlm.nih.gov/pubmed/22917002
http://dx.doi.org/10.1186/1471-2369-13-89

Ejemplares similares